Profil
Chan Yue Li currently works at Taiwan Liposome Co., Ltd., as Director from 2014.
Mr. Li also formerly worked at UBI Pharma Inc., as Director, Steminent Biotherapeutics, Inc., as Director, and Lin BioScience, Inc., as Director from 2016 to 2024.
Mr. Li received his graduate degree from the University of Iowa.
Postes actifs de Chan Yue Li
| Sociétés | Poste | Début |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Directeur/Membre du Conseil | 18/06/2014 |
Anciens postes connus de Chan Yue Li
| Sociétés | Poste | Fin |
|---|---|---|
| LIN BIOSCIENCE, INC. | Directeur/Membre du Conseil | 10/04/2024 |
| STEMINENT BIOTHERAPEUTICS INC. | Directeur/Membre du Conseil | - |
| UBI PHARMA INC. | Directeur/Membre du Conseil | - |
Formation de Chan Yue Li
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Steminent Biotherapeutics, Inc.
Steminent Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of stem cell drugs and technology for neurodegenerative disorders | Health Technology |
UBI Pharma Inc.
UBI Pharma Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells biopharmaceutical products | Health Technology |
Lin BioScience, Inc.
Lin BioScience, Inc. BiotechnologyHealth Technology Engages in discovering and development of drugs for cancer treatment and eye diseases | Health Technology |
















